← Human Trials & Peer-Reviewed Studies
Smoking cessation in women concerned about weight.
Plain-language guide to PMID 1503165 (1992): randomized controlled trial of Nicotine in 417 women.
Key Facts
- PMID
- 1503165
- Journal
- American journal of public health
- Year
- 1992
- Study type
- Randomized Controlled Trial
- Authors
- Pirie PL et al. (7 authors)
- DOI
- 10.2105/ajph.82.9.1238
What This Study Did, in Plain Language
What Was Tested
Researchers studied Nicotine in this randomized controlled trial publication.
A randomized trial of 417 women smokers was conducted to test the addition of two weight control strategies to a smoking cessation program.
Why It Was Studied
Weight gain after smoking cessation is often cited by women smokers as a primary reason for not attempting to quit smoking or for relapsing after a cessation attempt.
Who Took Part
The abstract describes 417 women taking part.
The age groups tagged for this paper are adults and middle-aged adults, women only.
Participants received the standard smoking cessation program, the program plus nicotine gum, the program plus behavioral weight control, or the program plus both nicotine gum and behavioral weight control.
Weight and smoking status were measured at the end of treatment and at 6 and 12 months posttreatment.
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Nicotine study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
Weight gain after smoking cessation is often cited by women smokers as a primary reason for not attempting to quit smoking or for relapsing after a cessation attempt.
PubMed files the paper under topics including Behavior Therapy, Chewing Gum, Nicotine and Smoking Cessation.
What This Means in Plain Language
The paper is a randomized study of Nicotine in 417 women.
With several hundred people or more, it is a fairly large study for this kind of research.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 1992 (American journal of public health), a journal based in United States.
More context: the related Therapeutic nicotine (patch, non-peptide) library page, all human trials.
Related Library Page
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.